These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 13664061)

  • 41. Endocrine effects on the heparin-induced lipemia-clearing activity (LCA) of rat plasma.
    CAIRNS A; CONSTANTINIDES P
    Can J Biochem Physiol; 1955 Jul; 33(4):530-8. PubMed ID: 13240523
    [No Abstract]   [Full Text] [Related]  

  • 42. Lipemia clearing effect of buccally administered heparin potassium (clarin).
    HIRSHLEIFER I; NAYAK R
    Am J Med Sci; 1961 May; 241():645-9. PubMed ID: 13714632
    [No Abstract]   [Full Text] [Related]  

  • 43. The alteration of the lipemia-clearing effect of heparin following the intravenous injection of thorium dioxide (thorotrast).
    LEQUIRE VS; GRAY ME; COBB CA
    Circ Res; 1953 Nov; 1(6):523-9. PubMed ID: 13106922
    [No Abstract]   [Full Text] [Related]  

  • 44. Relation of lipolysis to deturbidification and returbidification in heparin-induced lipemia-clearing phenomenon.
    GROSSMAN MI; STADLER J; CUSHING A; PALM L
    Proc Soc Exp Biol Med; 1955 Jan; 88(1):132-5. PubMed ID: 14357365
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum lipemia: an overlooked cause of tissue hypoxia.
    Engelberg H
    Cardiology; 1983; 70(5):273-9. PubMed ID: 6365311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PLASMA clearing effects of gastric mucin.
    Nutr Rev; 1959 Sep; 17():265-6. PubMed ID: 13858062
    [No Abstract]   [Full Text] [Related]  

  • 47. Demonstration of lipemia-clearing activity after sublingual administration of heparin potassium in the rabbit.
    MANGIERI CN; CAIN RA
    Angiology; 1961 Apr; 12():136-8. PubMed ID: 13766149
    [No Abstract]   [Full Text] [Related]  

  • 48. Blood coagulation during alimentary lipaemia in subjects with and without clinical evidence of atherosclerosis.
    MUSTARD JF
    Can Med Assoc J; 1958 Nov; 79(9):736-40. PubMed ID: 13585309
    [No Abstract]   [Full Text] [Related]  

  • 49. [Research on experimental hyperlipemia. IV. Effects of heparin on the inhibitor of the clarifying factor].
    Jouzier E; Tixier M; Tayeau F
    Bord Med; 1970 Sep; 3(9):2017-20. PubMed ID: 5481185
    [No Abstract]   [Full Text] [Related]  

  • 50. The virulence-enhancement factor of gastric mucin.
    GOULD JC; KING HK
    Biochem J; 1947; 41(2):xxi. PubMed ID: 20247706
    [No Abstract]   [Full Text] [Related]  

  • 51. [Action of a gastric mucin preparation and various vitamins on the most indicative hematochemical indices of atherosclerosis].
    CASTELLO S; SALVATORE V
    Clin Ter; 1963 Mar; 24():516-29. PubMed ID: 14019210
    [No Abstract]   [Full Text] [Related]  

  • 52. Atherosclerosis. IV. The relation of the composition of the blood lipids to atherosclerosis in experimental hyperlipemia.
    HIRSCH EF; NAILOR R
    AMA Arch Pathol; 1956 Jun; 61(6):469-87. PubMed ID: 13312835
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies on the lipid metabolism in experimental arteriosclerosis--relationship of hyperlipemia and plasma fatty acid compostion with development of atherosclerosis].
    Hao H
    Jpn Circ J; 1968 Dec; 32(12):1767-76. PubMed ID: 5756571
    [No Abstract]   [Full Text] [Related]  

  • 54. Post-heparin lipolytic activity in atherosclerotic hyperlipemic and obese patients.
    Cucuianu M; Popescu TA; Opincaru A
    J Atheroscler Res; 1968; 8(2):215-20. PubMed ID: 5664192
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pharmacological effect of a protamine derivative (compound "67-82") in subjects with hyperlipemia].
    DOMENGE L; HERNANDEZ C; HERNANDEZ REYES V; CARDENAS R
    Rev Invest Clin; 1961; 13():537-62. PubMed ID: 13887097
    [No Abstract]   [Full Text] [Related]  

  • 56. Serological characters of hog gastric mucin.
    CHADWICK DW; SMITH H
    Nature; 1949 Jul; 164(4158):61. PubMed ID: 18133537
    [No Abstract]   [Full Text] [Related]  

  • 57. On the identity of the virulence enhancement factor in gastric mucin.
    LANDY M; BATSON HC
    J Immunol; 1949 Aug; 62(4):477-85. PubMed ID: 18133629
    [No Abstract]   [Full Text] [Related]  

  • 58. [Dynamic study of lipolytic activity of post-heparin plasma in normal and atheromatous rabbits].
    Warembourg H; Biserte G; Bertrand M; Jaillard J; Sezille G
    C R Seances Soc Biol Fil; 1967; 161(11):2194-9. PubMed ID: 4232241
    [No Abstract]   [Full Text] [Related]  

  • 59. ORAL I-131 TRIOLEIN TOLERANCE CURVES IN NORMAL, ATHEROSCLEROTIC AND HYPERLIPAEMIC SUBJECTS.
    PRIOR IA; ARMSTRONG WE; CARR AH
    Australas Ann Med; 1963 Aug; 12():208-15. PubMed ID: 14058167
    [No Abstract]   [Full Text] [Related]  

  • 60. [Studies of gastric mucin. 2. Acid fixation by gastric mucin].
    KAPP H
    Gastroenterologia; 1950-1951; 76(3-4):195-9. PubMed ID: 14813390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.